Short answer
CNO Financial Group, Inc. (CNO) filed its Q3 2026 10-Q quarterly report on Nov 5, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $1.1B (down 8.6% year over year) with net income of $161M.
Q3 2026 key financials · XBRL
- Revenue
- $1.1B
- −8.6% YoY · −15.5% QoQ
- Net income
- $161M
- +597.4% YoY · +28.0% QoQ
- Operating margin
- 20.3%
- EPS (diluted)
- $1.70
- +580.0% YoY · +28.8% QoQ
Source: XBRL data from the CNO Financial Group, Inc. (CNO) Q3 2026 10-Q on SEC EDGAR. USD.
CNO Financial Group, Inc. Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Net operating income $179.1M, up from $127.2M YoY
- Operating ROE 14.1% vs 11.2% YoY; expense ratio 18.6% vs 19.2%
- Best segment: life margin $96.0M vs $70.6M; worst: health margin $149.1M vs $157.0M
- Cash $230.7M vs $150M minimum; $180.0M share repurchases and $50.4M dividends
- 2026 EPS guidance raised to $5.05-$5.15; Medicare Advantage sales down 7.9% and fee guidance reduced to $25M
Risk Factors
- No material changes from the December 31, 2025 Form 10-K risk factors
- General business risks could materially affect CNO’s operations
- Financial risks could materially affect CNO’s financial condition
- Previously disclosed risks remain applicable to CNO’s businesses
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other CNO Financial Group, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.